MEDESIS PHARMA S.A.
MEDESIS PHARMA ANNONCE LA CRÉATION D'UN CONSEIL SCIENTIFIQUE PERMANENT D'EXPERTS EN MALADIES NEURODEGENERATIVES
21 Nov 2022 18:00 CET
Subscribe
Issuer
MEDESIS PHARMA S.A.
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
16165_1120347_CP_ConseilScientifiqueNovembre2022_FR.pdf
Source
MEDESIS PHARMA
Provider
Les Echos
Company Name
MEDESIS PHARMA S.A.
ISIN
FR0010844464
Symbol
ALMDP
Market
Euronext Growth
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Medesis Pharma SA published this content on 21 November 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 November 2022 17:09:08 UTC.
